Skip to main content
. 2015 Sep 1;36(43):2996–3003. doi: 10.1093/eurheartj/ehv370

Figure 2.

Figure 2

Levels of calculated LDL-C over time (intention-to-treat analysis). ALI, alirocumab; PBO, placebo.